Westchester Capital Management (Nebraska)’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-100
| Closed | -$10K | – | 49 |
|
|
2022
Q3 | $10K | Hold |
100
| – | – | ﹤0.01% | 43 |
|
|
2022
Q2 | $11K | Buy |
+100
| New | +$11.9K | ﹤0.01% | 45 |
|
|
2021
Q1 | – | Sell |
-71,341
| Closed | -$10.7M | – | 58 |
|
|
2020
Q4 | $10.7M | Sell |
71,341
-556
| -0.8% | -$78.5K | 3.37% | 18 |
|
|
2020
Q3 | $9.5M | Sell |
71,897
-29
| -0% | -$3.79K | 3.37% | 17 |
|
|
2020
Q2 | $8.34M | Sell |
71,926
-1,160
| -2% | -$134K | 3.14% | 16 |
|
|
2020
Q1 | $7.17M | Buy |
73,086
+3,509
| +5% | +$460K | 3.21% | 19 |
|
|
2019
Q4 | $10.1M | Buy |
69,577
+96
| +0.1% | +$13.3K | 3.52% | 17 |
|
|
2019
Q3 | $9.26M | Buy |
69,481
+1,221
| +2% | +$158K | 3.63% | 16 |
|
|
2019
Q2 | $7.8M | Buy |
68,260
+3,654
| +6% | +$428K | 3.06% | 23 |
|
|
2019
Q1 | $8.01M | Sell |
64,606
-1,298
| -2% | -$148K | 3.43% | 21 |
|
|
2018
Q4 | $6.64M | Sell |
65,904
-824
| -1% | -$92.7K | 3.08% | 23 |
|
|
2018
Q3 | $8.52M | Buy |
66,728
+196
| +0.3% | +$23.3K | 3.38% | 20 |
|
|
2018
Q2 | $7.2M | Buy |
66,532
+74
| +0.1% | +$8.05K | 3.06% | 22 |
|
|
2018
Q1 | $7.04M | Sell |
66,458
-793
| -1% | -$92.1K | 2.97% | 23 |
|
|
2017
Q4 | $7.88M | Buy |
67,251
+1,453
| +2% | +$164K | 3.24% | 20 |
|
|
2017
Q3 | $7.48M | Buy |
65,798
+858
| +1% | +$99K | 3.21% | 21 |
|
|
2017
Q2 | $8.1M | Buy |
64,940
+2,680
| +4% | +$318K | 3.69% | 14 |
|
|
2017
Q1 | $7.38M | Buy |
62,260
+131
| +0.2% | +$14.8K | 3.54% | 18 |
|
|
2016
Q4 | $6.22M | Sell |
62,129
-1,375
| -2% | -$147K | 3.1% | 22 |
|
|
2016
Q3 | $8.02M | Sell |
63,504
-5,757
| -8% | -$711K | 3.9% | 12 |
|
|
2016
Q2 | $8.1M | Sell |
69,261
-618
| -0.9% | -$69.9K | 3.59% | 14 |
|
|
2016
Q1 | $7.23M | Buy |
69,879
+7,010
| +11% | +$678K | 3.26% | 21 |
|
|
2015
Q4 | $6.26M | Sell |
62,869
-675
| -1% | -$66K | 3.09% | 20 |
|
|
2015
Q3 | $5.79M | Buy |
63,544
+36
| +0.1% | +$3.61K | 3.1% | 21 |
|
|
2015
Q2 | $6.74M | Buy |
63,508
+923
| +1% | +$102K | 3.22% | 19 |
|
|
2015
Q1 | $7.14M | Sell |
62,585
-180
| -0.3% | -$20.5K | 3.53% | 17 |
|
|
2014
Q4 | $6.91M | Sell |
62,765
-495
| -0.8% | -$52.2K | 3.32% | 16 |
|
|
2014
Q3 | $6.17M | Buy |
63,260
+1,000
| +2% | +$98.4K | 2.92% | 21 |
|
|
2014
Q2 | $6.28M | Sell |
62,260
-129
| -0.2% | -$12.6K | 2.95% | 23 |
|
|
2014
Q1 | $5.73M | Buy |
62,389
+927
| +2% | +$85.4K | 2.88% | 23 |
|
|
2013
Q4 | $5.56M | Sell |
61,462
-376
| -0.6% | -$32.5K | 2.99% | 23 |
|
|
2013
Q3 | $4.93M | Sell |
61,838
-798
| -1% | -$62.8K | 3.06% | 23 |
|
|
2013
Q2 | $4.56M | Buy |
+62,636
| New | +$4.68M | 2.89% | 22 |
|
Other funds holding ZBH
Westchester Capital Management (Nebraska)'s ZBH Position: Q4 2022 in Review
Westchester Capital Management (Nebraska) sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 100 shares — an estimated $10K sold.
Westchester Capital Management (Nebraska) first reported a position in ZBH in Q2 2013 and held it in 33 quarters. The position peaked at $10.7M in Q4 2020. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.
- Westchester Capital Management (Nebraska) reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
- Westchester Capital Management (Nebraska) sold 100 Zimmer Biomet shares in Q4 2022, an estimated $10K.
- Westchester Capital Management (Nebraska) first reported a position in Zimmer Biomet in Q2 2013 and held it in 33 quarters.
- Westchester Capital Management (Nebraska)'s Zimmer Biomet position peaked at $10.7M in Q4 2020.
- 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.
Based on Westchester Capital Management (Nebraska)'s 13F filing for Q4 2022, filed 8 Feb 2023.